Comparison of Peritonsillar injection of mixture of Dexmedetomidine- Ropivacaine and tramadol - ?Ropivacaine in postoperative pain control and sedation after tonsillectomy under general anesthesia

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20141209020258N163

Enrollment

Registered

2021-07-18

Start date

2021-07-23

Completion date

Unknown

Last updated

2021-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tonsillectomy?. Acute tonsillitis, unspecified

Interventions

Intervention 1: Intervention group1: 5 millilitre of a solution containing Ropivacaine 0.25% and 1 µg / kg of dexmedetomidine will be injected as a peritonsillar. (Dexmedetomidine made by Elixir Compa

Eligibility

Sex/Gender

All

Age

3 Years to 12 Years

Inclusion criteria

Inclusion criteria: Candidate for tonsillectomy No metabolic glandular disease No coagulation disease No mental retardation Absence of peritonsillar abscess Absence of hypertension Absence of psychotic disorder Absence of chronic pain

Exclusion criteria

Exclusion criteria: Dissatisfaction with the patient or parents' own surgery

Design outcomes

Primary

Measure	Time frame
Sedation. Timepoint: 5 minutes, 15 minutes, 30 minutes, 1, 2, 4, 6, 12 and 24 hours after surgery. Method of measurement: Wilson sedation scale.;Pain. Timepoint: At 5 minutes, 15 minutes, 30 minutes, 1, 2, 4, 6, 12 and 24 hours after surgery. Method of measurement: Oucher? scale.;Total dose of narcotics. Timepoint: 24 hours after surgery. Method of measurement: Hospital file.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Esmaeel Moshiri

Arak University of Medical Sciences

modir.he@gmail.com+98 86 3222 2003

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026